Vor Biopharma Inc.

8-K

Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design

12/09/24

10-Q

ended 09/30/24 Q3

11/07/24

8-K

Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer

09/30/24

8-K

New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies

09/05/24

8-K

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

08/30/24

10-Q/A

ended 12/34/56 ## #### ####### #######

08/08/24

10-Q

ended 12/34/56 ##

08/08/24

8-K

###### ## ########## ######## ## ############

06/10/24

8-K

###### ## ########## ######## ## ############# ########### #### ######## ######### ########## ## ########

05/28/24

10-Q

ended 12/34/56 ##

05/09/24

DEFA14A

########## #### ##### ######## ####

05/02/24

8-K

### ######## ############ ######## ### ###### ############# ####### ########## ##### ######## ##### ## ### ##### ## #########

05/02/24

ARS

####### ##### ###### ###### ##########

04/09/24

DEFA14A

########## #### ##### ######## ####

04/09/24

DEF 14A

########## #####

04/09/24

S-8

############ ## ########## ### #########

03/21/24

10-K

ended 12/34/56 ## ####

03/20/24

8-K

######## ############

01/05/24

10-Q

ended 12/34/56 ##

11/07/23

8-K

######## ######## ### ########### ############# ## ### #### ######### ### ##### ##### #### ### ##### ########

11/02/23

Search in Documents

Key Exhibits

External Links

Latest Filings – Non-Ownership Filter

Latest Filings – Ownership Filter

Vor Biopharma Inc. Watch

Search in Documents

Key Exhibits

External Links

Latest Filings – Non-Ownership Filter

Latest Filings – Ownership Filter

Vor Biopharma Inc.